Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
104.08
-0.63 (-0.60%)
Nov 20, 2024, 4:00 PM EST - Market closed
Merit Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,326 | 1,257 | 1,151 | 1,075 | 963.88 | 994.85 | Upgrade
|
| Revenue Growth (YoY) | 8.12% | 9.24% | 7.09% | 11.50% | -3.11% | 12.70% | Upgrade
|
| Cost of Revenue | 704.99 | 673.49 | 631.88 | 589.42 | 562.7 | 562.49 | Upgrade
|
| Gross Profit | 620.88 | 583.87 | 519.1 | 485.33 | 401.18 | 432.37 | Upgrade
|
| Selling, General & Admin | 384.41 | 373.68 | 341.53 | 329.69 | 297.72 | 323.77 | Upgrade
|
| Research & Development | 83.91 | 82.73 | 75.51 | 71.25 | 57.54 | 65.62 | Upgrade
|
| Operating Expenses | 468.32 | 456.4 | 417.04 | 400.94 | 355.26 | 389.39 | Upgrade
|
| Operating Income | 152.56 | 127.47 | 102.06 | 84.4 | 45.92 | 42.98 | Upgrade
|
| Interest Expense | -28.2 | -15.51 | -6.34 | -5.26 | -9.99 | -12.41 | Upgrade
|
| Interest & Investment Income | 23.41 | 2.46 | 0.44 | 0.77 | 0.6 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.34 | 2 | 1.42 | -1.6 | -2.19 | -0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.71 | -0.8 | -0.45 | -0.91 | -0.61 | -0.52 | Upgrade
|
| EBT Excluding Unusual Items | 148.13 | 115.61 | 97.13 | 77.4 | 33.73 | 29.74 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -2.7 | - | -3.5 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.27 | -0.5 | - | -6 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.52 | - | Upgrade
|
| Asset Writedown | - | - | -1.72 | -1.58 | -30.5 | -3.25 | Upgrade
|
| Legal Settlements | - | - | -1 | -10.04 | -18.68 | - | Upgrade
|
| Other Unusual Items | 0.18 | -1.7 | -4.61 | -9.16 | 7.96 | -20.27 | Upgrade
|
| Pretax Income | 148.32 | 112.09 | 82.63 | 53.92 | -13.23 | 2.19 | Upgrade
|
| Income Tax Expense | 28.28 | 17.68 | 8.11 | 5.46 | -3.39 | -3.26 | Upgrade
|
| Net Income | 120.04 | 94.41 | 74.52 | 48.45 | -9.84 | 5.45 | Upgrade
|
| Net Income to Common | 120.04 | 94.41 | 74.52 | 48.45 | -9.84 | 5.45 | Upgrade
|
| Net Income Growth | 19.82% | 26.70% | 53.79% | - | - | -87.03% | Upgrade
|
| Shares Outstanding (Basic) | 58 | 58 | 57 | 56 | 55 | 55 | Upgrade
|
| Shares Outstanding (Diluted) | 59 | 58 | 58 | 57 | 55 | 56 | Upgrade
|
| Shares Change (YoY) | 0.96% | 1.19% | 0.54% | 3.47% | -1.42% | 4.27% | Upgrade
|
| EPS (Basic) | 2.07 | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | Upgrade
|
| EPS (Diluted) | 2.05 | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | Upgrade
|
| EPS Growth | 19.39% | 25.58% | 53.57% | - | - | -87.31% | Upgrade
|
| Free Cash Flow | 175.5 | 110.86 | 69.26 | 119.29 | 119.28 | -0.36 | Upgrade
|
| Free Cash Flow Per Share | 2.98 | 1.90 | 1.20 | 2.08 | 2.15 | -0.01 | Upgrade
|
| Gross Margin | 46.83% | 46.44% | 45.10% | 45.16% | 41.62% | 43.46% | Upgrade
|
| Operating Margin | 11.51% | 10.14% | 8.87% | 7.85% | 4.76% | 4.32% | Upgrade
|
| Profit Margin | 9.05% | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | Upgrade
|
| Free Cash Flow Margin | 13.24% | 8.82% | 6.02% | 11.10% | 12.38% | -0.04% | Upgrade
|
| EBITDA | 250.28 | 217.45 | 183.87 | 168.46 | 139.99 | 135.08 | Upgrade
|
| EBITDA Margin | 18.88% | 17.29% | 15.97% | 15.67% | 14.52% | 13.58% | Upgrade
|
| D&A For EBITDA | 97.72 | 89.99 | 81.8 | 84.07 | 94.07 | 92.1 | Upgrade
|
| EBIT | 152.56 | 127.47 | 102.06 | 84.4 | 45.92 | 42.98 | Upgrade
|
| EBIT Margin | 11.51% | 10.14% | 8.87% | 7.85% | 4.76% | 4.32% | Upgrade
|
| Effective Tax Rate | 19.06% | 15.77% | 9.82% | 10.13% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.